Company Roglstratlon Numbor: N1605880 Lllac Cancer Support Ltd (A company Ilmlted by guarantsè, not havino a •hAr• capltsl) Dlrectors. Report and Unaudited Financial Statements for the flnancial year ended 31 January 2023
Lilac Cancer Support Ltd (A company limit•d by guarantve, not havlng a ¥har• ¢apltall CONTENTS Pag8 Directors and Other Information Dir8clors' R8POrt Accountants. Report Income and Expendlture Account Balance Sheet Notes to the Financial Statements 9-10 Supplementary Information on Income and Expenditure Account 12
Lilac Cancer Support Ltd IA company Ilmitad by 9uaranleo, not havlng a sharg ¢aplt•ll DIRECTORS AND OTHER INFORMATION Dlroctors Bernadette Morgan Eamon Morga Julie ArTrn Mcalisler Sean Mccloskey {Reslgned 10 October 20221 Ann Walshe Yvonne Ggrvin Company R•glstratlon Number N1605880 Raglsterod Offlce 2nd Floor Loy Buildings 18 Loy Street Cookstown Tyrone 8T80 8PE Northern Ireland Bu•lno8• Addr••• 4 Barr8¢k Square Coallsland Tyrone BT714JG Northern Ireland Accountant• O'Hagan, McGllnchey & Co. Accounlanls 32-34 Dungannon Road Coallsland Tyrone 8T714HP Bankor• Ulster Bank Llmiled 39 Market Square Dungannon Co. Tyrone 8T70 1JJ
Lilac Cancer Support Ltd (A company limitod by guarant••, not havlng • •h*rg capltsll DIRECTORS. REPORT for the financial year ended 31 January 2023 The directors psent their report and the unaudited financlal statements for the financial year ended 31 January 2023. Prlnclpal Aetlvlty The company is a cancer charity. The Company Is Ilmlled by guarantee not havlng a share capltsl. Flnanclal R•$ults The surplus for the flnanc181 year after provldlng for depmciallon amounted to £3.00012022 - £2,724). Dlrectorn The directors who served during the financi81 year are as follow5.. Bemadelle Morgan Eamon Morgan Julie Ann M¢alSster Sean McClosk8y (Resigned 10 October 20221 Ann Walshe Yvonne Garvln There were no changes In shareholdlngs between 31 January 2023 and the dale ol signlng the financlal statements, In aceordan¢e wllh the Articl•s of Assoclalion, the dSreclors retiro by rolalion and, baing eligible, offer themselves for ro-election. Ststomonl ol Dlre¢tors' R••pon8lbllltl•• The dlroclors are responsible for-preparlng the Diig¢lor8' Report and the flnancial 8talemen18 In accordance with applicable law and regulallons. Con7pany law requir8$ the directors to prepare financial slalemenls for each Ilnanclal year. Under that law th6 directors have eleed to prepare thè financial statements in accordance with Unitèd Klngdom Generally Accepted A¢counllng Pracfjce (United Kingdom Accounllng Standards and 8ppIic8ble lawl Including FRS 102 'The Financlal Roportlng S18ndard applicable in Ihe UK and Republic of Ireland" Section 1A (Small Enlilies). Under company law the directo musl not approve the financSal slalgmenls unless they are satisfied that they glvo a true and falr view of the state of affairs of the company Bnd of tho surplus or deficit of tho company for that perlod. In prepan9 these financlal slalements, the directors are required lo: 801ecl 8uilablo accounllng pollcles and apply them consislenlly,. make Judgements and accounting 88llmales that are reasonable and prudent., prepare the financi81 slalemenls on the going concem basi5 unlèss 11 1$ inappropriate to presume that the company will continue in business. Tho directors are responsible for keeping adequate accounting records that ara suffici8nl to show and explaln the ompanls Iransacllons and dis¢1088 with reasonable aGGuracy at any Ilmg the flnancial position of tho company and enable them lo ensure that the financlal statements comply with tho Companie$ Act 2006. They are also responsible for Safeguarding the assets of the company and hence for laklng reasonabl8 steps for the prevention and dglecllon of fraud and olh&r irregularities.
Lilac Cancer Support Ltd IA company Ilmited by guaranteg. not havlno a •har• capltall DIRECTORS. REPORT for the finan¢ial year ended 31 January 2023 Speelal provlslons relating to small companles The above report has been prepared in accordance with the $pe¢i81 provisions relating lo small companies within Part 15 of tha Companies Act 2006. Onbe If of the board Dlr•ctor ernad8tt0 Morgan Olrgctor 20 March 2023
Lilac Cancer Support Ltd IA company limlt•d by guarantee. not havlng a shar• capltalj ACCOUNTANTS, REPORT to the Board of Directors on the Compilation of the unaudited financial statements of Lilac Cancer Support Ltd for the financial year ended 31 January 2023 In accordance with our engagement l&tter and in ordér lo assist you to fulfil your duties under the Companies Act 2006. we have compiled for your approval the financial statements of the company for tho financial year ended 31 January 2023 as set on pages 7 10 10 which comprise the Income and Exp6ndilure Account, the Balance Sheet and the related notss from the company's aG¢ounting records and from Information and explanations you have given to us. Thls réport Is made solgly to the Board of Directors of Lilac Cancer Support Ltd. as a boily, Sn accordance with the terms of our engag8m&nl. Our work has been undertaken so that we might compllè the flnancial statements that w& havo been 8ngag8d lo Compile, report lo the company's Board of Directors that we have dong $0, an(1 slate Ihosa matters that we hav6 aged to slate to them in this report and for no olhgr purpose. To the fullest exlont pem)illed by law. we do not accept or assume r85ponsibilily lo anyone other than the Lllac Cancer Support Ltd and its Board of Olr8Gtors, as a l)ody, for our work or for this r&port. We have carrled out Ihls engagemènt accordance wllh guldance Issued by accounllng standards and havo complied with the ¢thic81 guldance laid down by aocounling 8landard$ relallng lo members undertaking th compilation of finan¢ial 8ta19menls. You hav8 acknowledged on the balance sheet for the year ended 31 January 2023 your duly lo ensure that Llla Cancer Support Ltd has kept adequate a¢cotJnling ffjcords and lo prepare slalulory flnanclal slalemenls that give a true and fair view of tho assets, Ilabllllles, fln8ncial position and surplus of Lilac Cancer Support Ltd. You consider that Lllac Cancer Support Ltd is exompl fmm thg slalulory audit requirement for the financial year. We have not been Instructed lo Carry out an audit or a review of the financial statements of Lilac Can¢er Support Ltd For Ihls rea$on, we have not verlfied the accuracy or completene$5 of the accounllng records or Snformallon and explanatlons you have glven k) us and we do not, Ihergfore, express any oplnion on the stalulory financial talomenls. O'HAGAN, MCGLINCHEY & CO. Accountants 32-34 Dungannon Road Co8llsland Tyrone BT714HP 23 March 2023
Lilac Cancer Support Ltd (A cornpany 1Smited by guarantee, not havlng a $har• ¢apltall INCOME AND EXPENDITURE ACCOUNT for the financial yaar ended 37 January 2023 2023 Notes 2022 Income 152,192 137,672 Expendhurn (149,192} 1134.9481 Surpluj for th• flnanelal yoar Total comprehfjn81vo Incom• Retained surplus brought foNard Rotain•d •urplu¥ ¢arrlod forward 3,000 2,724 3.000 2,724 118,762 116,038 121,762 118.762 The notgs on pagtrs 9 to 10 frjrrn part ofthe financial atatements
Lilae Cancer Support Ltd (A Company Ilmltgd by guarant•¢, not having 41 8h*r• rApltall Company Règistration Numb•r'. NI005880 BALANCE SHEET as at 31 January 2023 2023 2022 Notes Flxéd A8Bets Tangible assets 20.188 25.417 Curront A880ts Stocks Cash and cash equlvalenls 5,500 97,040 5,745 88,300 102.540 94,045 Crodltorn: amounts falllng due wlthln on• y••r Not Currert Asi•ts (966) 1700) 101,574 93,345 Total Assots1018 Curront Llabllltl•s 121,762 118,762 Re80rv08 Incomo and expenditure 8c¢ounl 121,762 118.762 Equlty attrlbutabl& to own•r• of th• company 121,702 118,762 The financlal statements have been pr8pared In accordance with the proviÈlon8 appllcable lo companies sublecl to the sm811 eompanla$' reglme and In a¢¢ordanGe wllh the provlslons of FRS 102 Section IA {Small Enlilias). For the financial year ended 31 January 2023 the company w88 enlilled to oxemplion from audit und&r secllon 477 of the Companie8 Act 2006. The dlrectors confimi that the members have not required the company lo obtaln an audll of 118 financlal ¥lalemen18 for the flnanclal year In quesllon In accordanc8 wllh $ectlon 476 of the Companles t 2006. Th8 dlr8¢tors acknowledgè Ihair re8ponsibili119s for ensuring that the company keeps accounllng record$ which comply with section 386 and for preparing finan¢ial slalements whSch give a true and fair view of the slate of affairs of the company as al the end of the financial year and of ils profil and loss for the finanGial year in a¢cord8n¢e with the requir8menl$ of seGlion8 394 and 395 and which otheise comply wlth the roquiremenls of the Companies Act 2006 relallng to flnanclal stalemenls. so far a5 applicable to the company. Appro by th• 8oard and •ulhorl•od for Is•u• on 20 M•rch 2023 and •lgn•d on It8 behalf by alsh• Dlrector Bgrnadotte Morgan DireGtor The notes on pag85 g to 10 form part of the fin8nGial 8tatem¢nt8
Lllac Cancer Support Ltd NOTES TO THE FINANCIAL STATEMENTS for the financial year ended 31 January 2023 G•neral Infomiatlon Lila¢ Cancer Support Ltd is a company limited by guarant89 incorporated in Northern Ireland. 2nd Floor, Loy Building8. 18 Loy Street, Cookstown, Tyrone, BT80 8PE, Northern Ireland is the registered office, which is also the princlpal place of busln&s5 of the company. Thè nature of the company's operations and ils principal acuvilies are sel out in the Dlrectors, Report. The financlal statements have been presented in Pound 1£) which is also the functional currency of the company. Summary of Slgnlfl¢ant A¢countlng Pollclos The following accounting policiés havg bean applied consislenlly In deallng wlth Items which arè consider8d material in r6lation lo the company's financlal slatgments. Statsment of compllance The finan81 stslemenls of the company for the year ended 31 January 2023 have been prep8red In accordance wllh th8 provlgion8 of FRS 102 Section 1A (Small Entities) and the Companies Act 2006. Basls of proparatlon The financ181 st81emenl$ have been prepargd on the going concèrn b8SIS and In accordance wlth the hlsloncal cost convention except for certain propertles and financial instrum8nl$ that are measured al revalued amoun18 or falr valua$, as explalned in the aecounllng policles below. Hlstorical cost Is generally based on the falr value of the conslderallon glven In exchange for assets. Incom• Tumover compdses charlty Shop sal88, donations, fundr8181ng, grants reGeived and olher Gharitable aclivS118S. Tanglbl• a88ot8 and depreclatlon Tanglble as$e15 are Staled al cost or at valu8llon, less a¢Gumulated depreclalion. The charge lo deprec1811on 1$ calculated lo Wte off the ortglnal cost or valuallon of tangible assets. less their &slimatèd resldual value, over Ih8ir expected usefttl lives as follows.. Plant Bnd machinery Flxlures, fittings and equipment Motor vehide8 25% Reducing balancè 25gA Reducing balancg 25°A Reducing balance The carying values of tangibfe fixed assets are reviewed annually for Impalrmenl in p8rlods if events or change8 In cirGumslances Indlcale the carying valu6 may nol be recoverable. 8to¢ks Stocks are valued at the lower of cost and nel realisablo value. Cost comprises expendllure incurred In the normal course of busingss in bringlng Stocks to their present location and condition. Full provision is made for obsolete and slow moving Stems. Net realisable value comprisgs aclual or esllmated selling prlce In6t of trade dlscounts} less all further costs to completion or lo be incurr8d In markellng and selling. Tr•do and oth•r ¢r•dltor8 Trade and other Creditors are ini118lly recognised al fair value and thereafter staled at amortised Cost using the effective interest rale method, unless the effecl of diswunting would be immaterial, in whiGh case they are 8ts1ed at cost. Taxatlon Employees The averag8 monthly number of employees. including dlredors, during the financial year was 4, {2022 - 4).
Lilac Cancer Support Ltd NOTES TO THE FINANCIAL STATEMENTS for the flnancial y8ar ènded 31 January 2023 Tangible assets conkn'nued Plant and Flxtures, machlnery flttlngs and equlpment Motor vehicles Total Cost At 1 Febrnary 2022 Addition8 26,618 1,500 16,945 20,362 63.925 1,500 At 31 January 2023 28.118 16,945 20,362 65,425 D•preclatlon At 1 February 2022 Charge for th& fi'nancl81 y8ar At 31 January 2023 9,712 4,601 10.973 1,493 17,823 635 38,508 6.729 14,313 12.466 18.458 45,237 N•1 book value At 31 January 2023 13,805 4.479 1,904 20.188 At 31 January 2022 16,906 5.972 2,539 25,417 Slock• 2023 2022 Flnl8h8d goods and gt)od8 for resale 5,500 5,745 The repl8¢ement C081 of Stock dld not dlffer $ignifi¢anlly from Ihe flguies shown. Credltor8 Amount8 falllng du• wlthln on• yoar Taxation (Note 71 Accru81$ 2023 2022 266 700 700 966 700 Taxatlon 2023 2022 Credltors.. PAYE I NI 266 Income 81atement 2023 2022 At 1 February 2022 Surplus for the finandal year At 31 January 2023 118,762 3,000 116,038 2,724 121.762 118.762 The following reslrlct8d funds (total of £21,000) ar8 included in Reserves al 31101123: £9,000- Trusthouse. Nationwide, Hallfax £12,000- Redundancy Reserve 10
LILA CANCER SUPPORT LTD IA eompany Ilmlted by guarant•o. not havlng a 8har• caplt•l) SUPPLEMENTARY INFORMATION RE TING TO THE FINANCIAL STA EME TS Fl 11
Lilac Cancer Support Ltd IA company limit•d by guarantee. not havlng a 6har• capital) SUPPLEMENTARY INFORMATION RELATING TO THE FINANCIAL STATEMENTS DETAILED INCOME AND EXPENDITURE ACCOUNT for the financial year ended 31 January 2023 2023 2022 Income Shop takings Grants Fundraislng & Donations othor Income Rental Income Govemment grant income 78,312 50,993 10,245 11,742 900 32.664 43,802 25,9g3 10,719 1,800 22,694 152.192 137,672 Exp•ndlture Acllvilies Flowers, Gifts and Donatlons Helpar8 Staff pension scheme cost8 Movement in stock Wages and salari&9 Rent payable Rat8S Insurance Light and heat Repairs and maintananco Advertising, stallonery and postage Telephon8 Motor expenses Leg81 and piofes$lon81 Accountancy 88nk charges General oxpens88 Subscrlptions Depreclallon 18,175 17,557 255 9,604 1,711 {295) 54,628 13.645 557 3,220 2,271 9,171 779 3,139 4,296 2,440 2,349 418 264 467 8,472 12,232 2,332 245 65,303 12,950 677 3.261 3,349 8.671 746 3.075 8,423 792 1,531 148 29 524 6.729 149,192 134,948 N•t •urplu• 3,000 2.724 Thè supplem$ntary information does not form part of the financial statements 12